Sagimet Biosciences, Inc. Class A Financial Overview
Sagimet Biosciences, Inc. Class A's market cap is currently $227.55M. The company's EPS TTM is $-0.32; its P/E ratio is ―; Sagimet Biosciences, Inc. Class A is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in USD
Sagimet Biosciences, Inc. Class A Earnings and Revenue History
